How DEHP May Promote Liver Scarring by Activating Fat Breakdown in Liver Support Cells

Subchronic exposure to di(2-ethylhexyl)phthalate (DEHP) at doses of 50-500 mg/kg induced dose-dependent hepatic fibrosis in mice.

• DEHP is associated with hepatic fibrosis, a condition where liver tissue becomes scarred.
• Lipid metabolism and autophagy pathways may play a role in DEHP-related hepatic fibrosis.
• The metabolite MEHP can enhance the activation of hepatic stellate cells (HSCs) when combined with TGF-β1 in cell studies.
• MEHP activates a specific type of cellular breakdown process called lipophagy, targeting a protein known as Beclin1.
• Inhibiting autophagy through specific compounds or by reducing Beclin1 expression can reverse the activation of HSCs caused by MEHP.
• The findings suggest that DEHP could act as a trigger for liver fibrosis by promoting HSC activation.

Simplified